{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:28:20Z","timestamp":1778876900388,"version":"3.51.4"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Searching for potential inhibitors of GSK-3\u03b2 from marine compounds using computational models and ADMET tools"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s11030-025-11174-x","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T06:09:36Z","timestamp":1743746976000},"page":"483-493","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Searching potential GSK-3\u03b2 inhibitors from marine sources using atomistic simulations"],"prefix":"10.1007","volume":"30","author":[{"given":"Tran Thi Hoai","family":"Van","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minh Quan","family":"Pham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Truong Thi Thu","family":"Huong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bui Nguyen Thanh","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pham Quoc","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le Thi Thuy","family":"Huong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George Binh","family":"Lenon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nguyen Thi Thanh","family":"Uyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Son Tung","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"issue":"5","key":"11174_CR1","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1016\/j.talanta.2011.08.034","volume":"85","author":"S Nussbaumer","year":"2011","unstructured":"Nussbaumer S, Bonnabry P, Veuthey J-L, Fleury-Souverain S (2011) Analysis of anticancer drugs: a review. Talanta 85(5):2265\u20132289. https:\/\/doi.org\/10.1016\/j.talanta.2011.08.034","journal-title":"Talanta"},{"issue":"3","key":"11174_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"11174_CR3","first-page":"48","volume":"2","author":"G Bethune","year":"2011","unstructured":"Bethune G, Bethune D, Ridgway N, Xu Z (2011) Epidermal growth factor receptor (EGFR) in lung cancer: an overview and update. J Thorac Dis 2(1):48\u201351","journal-title":"J Thorac Dis"},{"issue":"13","key":"11174_CR4","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.1158\/1078-0432.Ccr-08-0168","volume":"14","author":"JP Koivunen","year":"2008","unstructured":"Koivunen JP, Mermel C, Zejnullahu K, Murphy C, Lifshits E, Holmes AJ et al (2008) EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer. Clin Cancer Res 14(13):4275\u20134283. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-08-0168","journal-title":"Clin Cancer Res"},{"issue":"4","key":"11174_CR5","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s40265-014-0182-z","volume":"74","author":"B Piperdi","year":"2014","unstructured":"Piperdi B, Merla A, Perez-Soler R (2014) Targeting angiogenesis in squamous non-small cell lung cancer. Drugs 74(4):403\u2013413. https:\/\/doi.org\/10.1007\/s40265-014-0182-z","journal-title":"Drugs"},{"issue":"1","key":"11174_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/BF00683195","volume":"27","author":"R Lupu","year":"1993","unstructured":"Lupu R, Lippman ME (1993) The role of erbB2 signal transduction pathways in human breast cancer. Breast Cancer Res 27(1):83\u201393. https:\/\/doi.org\/10.1007\/BF00683195","journal-title":"Breast Cancer Res"},{"issue":"16","key":"11174_CR7","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.2217\/fon.15.162","volume":"11","author":"S Sundararajan","year":"2015","unstructured":"Sundararajan S, Vogelzang NJ (2015) Anti-PD-1 and PD-L1 therapy for bladder cancer: what is on the horizon? Future Oncol 11(16):2299\u20132306. https:\/\/doi.org\/10.2217\/fon.15.162","journal-title":"Future Oncol"},{"issue":"1","key":"11174_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.beha.2012.01.004","volume":"25","author":"B Bisig","year":"2012","unstructured":"Bisig B, Gaulard P, de Leval L (2012) New biomarkers in T-cell lymphomas. Baillieres Best Pract Res Clin Rheumatol 25(1):13\u201328. https:\/\/doi.org\/10.1016\/j.beha.2012.01.004","journal-title":"Baillieres Best Pract Res Clin Rheumatol"},{"issue":"2","key":"11174_CR9","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/j.1432-1033.1980.tb06059.x","volume":"107","author":"N Embi","year":"2005","unstructured":"Embi N, Rylatt DB, Cohen P (2005) Glycogen synthase kinase-3 from rabbit skeletal muscle. Eur J Biochem 107(2):519\u2013527. https:\/\/doi.org\/10.1111\/j.1432-1033.1980.tb06059.x","journal-title":"Eur J Biochem"},{"issue":"1","key":"11174_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2217\/14796694.2.1.91","volume":"2","author":"AV Ougolkov","year":"2006","unstructured":"Ougolkov AV, Billadeau DD (2006) Targeting GSK-3: a promising approach for cancer therapy? Future Oncol 2(1):91\u2013100. https:\/\/doi.org\/10.2217\/14796694.2.1.91","journal-title":"Future Oncol"},{"issue":"6","key":"11174_CR11","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1016\/j.ejmech.2008.08.012","volume":"44","author":"S Vadivelan","year":"2009","unstructured":"Vadivelan S, Sinha BN, Tajne S, Jagarlapudi SARP (2009) Fragment and knowledge-based design of selective GSK-3\u03b2 inhibitors using virtual screening models. Eur J Med Chem 44(6):2361\u20132371. https:\/\/doi.org\/10.1016\/j.ejmech.2008.08.012","journal-title":"Eur J Med Chem"},{"issue":"1","key":"11174_CR12","doi-asserted-by":"publisher","first-page":"11429","DOI":"10.1038\/s41598-020-68134-8","volume":"10","author":"NT Dan","year":"2020","unstructured":"Dan NT, Quang HD, Van Truong V, Huu Nghi D, Cuong NM, Cuong TD et al (2020) Design, synthesis, structure, in vitro cytotoxic activity evaluation and docking studies on target enzyme GSK-3\u03b2 of new indirubin-3\u2019-oxime derivatives. Sci Rep 10(1):11429. https:\/\/doi.org\/10.1038\/s41598-020-68134-8","journal-title":"Sci Rep"},{"issue":"12","key":"11174_CR13","doi-asserted-by":"publisher","first-page":"4580","DOI":"10.1158\/1078-0432.CCR-04-2624","volume":"11","author":"JC Ghosh","year":"2005","unstructured":"Ghosh JC, Altieri DC (2005) Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3\u03b2 in colorectal cancer cells. Clin Cancer Res 11(12):4580\u20134588. https:\/\/doi.org\/10.1158\/1078-0432.CCR-04-2624","journal-title":"Clin Cancer Res"},{"issue":"10","key":"11174_CR14","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1111\/cas.13028","volume":"107","author":"T Domoto","year":"2016","unstructured":"Domoto T, Pyko IV, Furuta T, Miyashita K, Uehara M, Shimasaki T et al (2016) Glycogen synthase kinase-3\u03b2 is a pivotal mediator of cancer invasion and resistance to therapy. Cancer Sci 107(10):1363\u20131372. https:\/\/doi.org\/10.1111\/cas.13028","journal-title":"Cancer Sci"},{"issue":"6","key":"11174_CR15","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.3390\/cells9061388","volume":"9","author":"T Domoto","year":"2020","unstructured":"Domoto T, Uehara M, Bolidong D, Minamoto T (2020) Glycogen synthase kinase 3\u03b2 in cancer biology and treatment. Cells 9(6):1388","journal-title":"Cells"},{"issue":"3","key":"11174_CR16","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1021\/acs.jnatprod.5b01055","volume":"79","author":"DJ Newman","year":"2016","unstructured":"Newman DJ, Cragg GM (2016) Natural products as sources of new drugs from 1981 to 2014. J Nat Prod 79(3):629\u2013661. https:\/\/doi.org\/10.1021\/acs.jnatprod.5b01055","journal-title":"J Nat Prod"},{"issue":"19","key":"11174_CR17","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.1007\/s00018-018-2872-2","volume":"75","author":"Z Dhouafli","year":"2018","unstructured":"Dhouafli Z, Cuanalo-Contreras K, Hayouni EA, Mays CE, Soto C, Moreno-Gonzalez I (2018) Inhibition of protein misfolding and aggregation by natural phenolic compounds. Cell Mol Life Sci 75(19):3521\u20133538. https:\/\/doi.org\/10.1007\/s00018-018-2872-2","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"11174_CR18","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1080\/07391102.2018.1456975","volume":"37","author":"P Ambure","year":"2019","unstructured":"Ambure P, Bhat J, Puzyn T, Roy K (2019) Identifying natural compounds as multi-target-directed ligands against alzheimer\u2019s disease: an in silico approach. J Biomol Struct Dyn 37(5):1282\u20131306. https:\/\/doi.org\/10.1080\/07391102.2018.1456975","journal-title":"J Biomol Struct Dyn"},{"issue":"6","key":"11174_CR19","doi-asserted-by":"publisher","first-page":"e0179428","DOI":"10.1371\/journal.pone.0179428","volume":"12","author":"J Chiriv\u00ed","year":"2017","unstructured":"Chiriv\u00ed J, Danies G, Sierra R, Schauer N, Trenkamp S, Restrepo S et al (2017) Metabolomic profile and nucleoside composition of cordyceps nidus sp. Nov. (Cordycipitaceae): a new source of active compounds. PLoS ONE 12(6):e0179428. https:\/\/doi.org\/10.1371\/journal.pone.0179428","journal-title":"PLoS ONE"},{"issue":"6","key":"11174_CR20","doi-asserted-by":"publisher","first-page":"E1009","DOI":"10.1073\/pnas.1610586114","volume":"114","author":"M Perni","year":"2017","unstructured":"Perni M, Galvagnion C, Maltsev A, Meisl G, Muller MBD, Challa PK et al (2017) A natural product inhibits the initiation of alpha-synuclein aggregation and suppresses its toxicity. Proc Natl Acad Sci USA 114(6):E1009\u2013E1017. https:\/\/doi.org\/10.1073\/pnas.1610586114","journal-title":"Proc Natl Acad Sci USA"},{"issue":"15","key":"11174_CR21","doi-asserted-by":"publisher","first-page":"5987","DOI":"10.1021\/jm400161p","volume":"56","author":"T Stoilova","year":"2013","unstructured":"Stoilova T, Colombo L, Forloni G, Tagliavini F, Salmona M (2013) A new face for old antibiotics: tetracyclines in treatment of amyloidoses. J Med Chem 56(15):5987\u20136006. https:\/\/doi.org\/10.1021\/jm400161p","journal-title":"J Med Chem"},{"issue":"1","key":"11174_CR22","doi-asserted-by":"publisher","first-page":"5648","DOI":"10.1038\/srep05648","volume":"4","author":"H Gong","year":"2014","unstructured":"Gong H, He Z, Peng A, Zhang X, Cheng B, Sun Y et al (2014) Effects of several quinones on insulin aggregation. Sci Rep 4(1):5648. https:\/\/doi.org\/10.1038\/srep05648","journal-title":"Sci Rep"},{"issue":"9","key":"11174_CR23","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1016\/j.bbamem.2018.03.012","volume":"1860","author":"MFM Sciacca","year":"2018","unstructured":"Sciacca MFM, Chillemi R, Sciuto S, Greco V, Messineo C, Kotler SA et al (2018) A blend of two resveratrol derivatives abolishes hIAPP amyloid growth and membrane damage. Biochim Biophys Acta-Biomembr 1860(9):1793\u20131802. https:\/\/doi.org\/10.1016\/j.bbamem.2018.03.012","journal-title":"Biochim Biophys Acta-Biomembr"},{"issue":"5","key":"11174_CR24","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1074\/jbc.M110.173856","volume":"286","author":"ARA Ladiwala","year":"2011","unstructured":"Ladiwala ARA, Dordick JS, Tessier PM (2011) Aromatic small molecules remodel toxic soluble oligomers of amyloid \u03b2 through Three independent pathways. J Biol Chem 286(5):3209\u20133218. https:\/\/doi.org\/10.1074\/jbc.M110.173856","journal-title":"J Biol Chem"},{"key":"11174_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jmgm.2017.06.018","volume":"76","author":"ST Ngo","year":"2017","unstructured":"Ngo ST, Truong DT, Tam NM, Nguyen MT (2017) EGCG inhibits the oligomerization of amyloid beta (16\u201322) hexamer: theoretical studies. J Mol Graph Model 76:1\u201310. https:\/\/doi.org\/10.1016\/j.jmgm.2017.06.018","journal-title":"J Mol Graph Model"},{"issue":"12","key":"11174_CR26","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s10822-018-0175-1","volume":"32","author":"E Srinivasan","year":"2018","unstructured":"Srinivasan E, Rajasekaran R (2018) Quantum chemical and molecular mechanics studies on the assessment of interactions between resveratrol and mutant SOD1 (G93A) protein. J Comput Aided Mol Des 32(12):1347\u20131361. https:\/\/doi.org\/10.1007\/s10822-018-0175-1","journal-title":"J Comput Aided Mol Des"},{"issue":"12","key":"11174_CR27","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/s1359-6446(03)02713-2","volume":"8","author":"B Haefner","year":"2003","unstructured":"Haefner B (2003) Drugs from the deep: marine natural products as drug candidates. Drug Discovery Today 8(12):536\u2013544. https:\/\/doi.org\/10.1016\/s1359-6446(03)02713-2","journal-title":"Drug Discovery Today"},{"issue":"2","key":"11174_CR28","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1023\/A:1002405815493","volume":"77","author":"DJ Faulkner","year":"2000","unstructured":"Faulkner DJ (2000) Marine pharmacology. Antonie Van Leeuwenhoek 77(2):135\u2013145. https:\/\/doi.org\/10.1023\/A:1002405815493","journal-title":"Antonie Van Leeuwenhoek"},{"issue":"1","key":"11174_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nrd2487","volume":"8","author":"TF Molinski","year":"2008","unstructured":"Molinski TF, Dalisay DS, Lievens SL, Saludes JP (2008) Drug development from marine natural products. Nat Rev Drug Discovery 8(1):69\u201385. https:\/\/doi.org\/10.1038\/nrd2487","journal-title":"Nat Rev Drug Discovery"},{"issue":"11","key":"11174_CR30","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1039\/c4np00064a","volume":"31","author":"MS Butler","year":"2014","unstructured":"Butler MS, Robertson AAB, Cooper MA (2014) Natural product and natural product derived drugs in clinical trials. Nat Prod Rep 31(11):1612\u20131661. https:\/\/doi.org\/10.1039\/c4np00064a","journal-title":"Nat Prod Rep"},{"key":"11174_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.rsma.2022.102619","volume":"56","author":"PM Quan","year":"2022","unstructured":"Quan PM, Anh HBQ, Hang NTN, Toan DH, Ha DV, Long PQ (2022) Marine derivatives prevent E6 protein of HPV: an in silico study for drug development. Reg Stud Mar Sci 56:102619. https:\/\/doi.org\/10.1016\/j.rsma.2022.102619","journal-title":"Reg Stud Mar Sci"},{"issue":"4","key":"11174_CR32","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1021\/acs.jctc.0c01045","volume":"17","author":"D Patel","year":"2021","unstructured":"Patel D, Patel JS, Ytreberg FM (2021) Implementing and assessing an alchemical method for calculating protein\u2013protein binding free energy. J Chem Theor Compt 17(4):2457\u20132464. https:\/\/doi.org\/10.1021\/acs.jctc.0c01045","journal-title":"J Chem Theor Compt"},{"issue":"9","key":"11174_CR33","doi-asserted-by":"publisher","first-page":"4733","DOI":"10.1021\/acs.jcim.1c00515","volume":"61","author":"V Bonatto","year":"2021","unstructured":"Bonatto V, Shamim A, Rocho FdR, Leit\u00e3o A, Luque FJ, Lameira J et al (2021) Predicting the relative binding affinity for reversible covalent inhibitors by free energy perturbation calculations. J Chem Inf Model 61(9):4733\u20134744. https:\/\/doi.org\/10.1021\/acs.jcim.1c00515","journal-title":"J Chem Inf Model"},{"issue":"11","key":"11174_CR34","doi-asserted-by":"publisher","first-page":"5829","DOI":"10.1021\/acs.jctc.9b00499","volume":"15","author":"D Suh","year":"2019","unstructured":"Suh D, Jo S, Jiang W, Chipot C, Roux B (2019) String method for protein\u2013protein binding free-energy calculations. J Chem Theory Comput 15(11):5829\u20135844. https:\/\/doi.org\/10.1021\/acs.jctc.9b00499","journal-title":"J Chem Theory Comput"},{"issue":"9","key":"11174_CR35","doi-asserted-by":"publisher","first-page":"5520","DOI":"10.1021\/acs.chemrev.5b00630","volume":"116","author":"U Ryde","year":"2016","unstructured":"Ryde U, Soderhjelm P (2016) Ligand-binding affinity estimates supported by quantum-mechanical methods. Chem Rev 116(9):5520\u20135566. https:\/\/doi.org\/10.1021\/acs.chemrev.5b00630","journal-title":"Chem Rev"},{"issue":"10","key":"11174_CR36","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1021\/acs.jcim.6b00290","volume":"56","author":"G Subramanian","year":"2016","unstructured":"Subramanian G, Ramsundar B, Pande V, Denny RA (2016) Computational modeling of \u03b2-secretase 1 (BACE-1) inhibitors using ligand based approaches. J Chem Inf Model 56(10):1936\u20131949. https:\/\/doi.org\/10.1021\/acs.jcim.6b00290","journal-title":"J Chem Inf Model"},{"key":"11174_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemphys.2022.111709","volume":"564","author":"TH Nguyen","year":"2023","unstructured":"Nguyen TH, Tam NM, Tuan MV, Zhan P, Vu VV, Quang DT et al (2023) Searching for potential inhibitors of SARS-COV-2 main protease using supervised learning and perturbation calculations. Chem Phys 564:111709. https:\/\/doi.org\/10.1016\/j.chemphys.2022.111709","journal-title":"Chem Phys"},{"issue":"1","key":"11174_CR38","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1124\/pr.112.007336","volume":"66","author":"G Sliwoski","year":"2014","unstructured":"Sliwoski G, Kothiwale S, Meiler J, Lowe EW (2014) Computational methods in drug discovery. Pharmacol Rev 66(1):334\u2013395. https:\/\/doi.org\/10.1124\/pr.112.007336","journal-title":"Pharmacol Rev"},{"key":"11174_CR39","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/978-1-4939-6634-9_5","volume-title":"Antibiotics: methods and protocols","author":"W Yu","year":"2017","unstructured":"Yu W, MacKerell AD (2017) Computer-aided drug design methods. In: Sass P (ed) Antibiotics: methods and protocols. Springer, New York, pp 85\u2013106"},{"issue":"10","key":"11174_CR40","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s10822-007-9142-y","volume":"21","author":"JH Van Drie","year":"2007","unstructured":"Van Drie JH (2007) Computer-aided drug design: the next 20 years. J Comput Aided Mol Des 21(10):591\u2013601. https:\/\/doi.org\/10.1007\/s10822-007-9142-y","journal-title":"J Comput Aided Mol Des"},{"issue":"2","key":"11174_CR41","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1080\/07391102.2020.1817787","volume":"40","author":"R Majumder","year":"2022","unstructured":"Majumder R, Mandal M (2022) Screening of plant-based natural compounds as a potential COVID-19 main protease inhibitor: an in silico docking and molecular dynamics simulation approach. J Biomol Struct Dyn 40(2):696\u2013711. https:\/\/doi.org\/10.1080\/07391102.2020.1817787","journal-title":"J Biomol Struct Dyn"},{"issue":"17","key":"11174_CR42","doi-asserted-by":"publisher","first-page":"11278","DOI":"10.1039\/D3RA01145C","volume":"13","author":"H Nassar","year":"2023","unstructured":"Nassar H, Sippl W, Dahab RA, Taha M (2023) Molecular docking, molecular dynamics simulations and in vitro screening reveal cefixime and ceftriaxone as GSK3\u03b2 covalent inhibitors. RSC Adv 13(17):11278\u201311290. https:\/\/doi.org\/10.1039\/D3RA01145C","journal-title":"RSC Adv"},{"issue":"10","key":"11174_CR43","doi-asserted-by":"publisher","DOI":"10.1098\/rsos.240546","volume":"11","author":"QM Thai","year":"2024","unstructured":"Thai QM, Pham MQ, Tran P-T, Nguyen TH, Ngo ST (2024) Searching for potential acetylcholinesterase inhibitors: a combined approach of multi-step similarity search, machine learning and molecular dynamics simulations. R Soc Open Sci 11(10):240546. https:\/\/doi.org\/10.1098\/rsos.240546","journal-title":"R Soc Open Sci"},{"issue":"5","key":"11174_CR44","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/j.1751-7915.2010.00179.x","volume":"3","author":"A Debbab","year":"2010","unstructured":"Debbab A, Aly AH, Lin WH, Proksch P (2010) Bioactive compounds from marine bacteria and fungi. Microb Biotechnol 3(5):544\u2013563. https:\/\/doi.org\/10.1111\/j.1751-7915.2010.00179.x","journal-title":"Microb Biotechnol"},{"key":"11174_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.02536","author":"SK Deshmukh","year":"2018","unstructured":"Deshmukh SK, Prakash V, Ranjan N (2018) Marine fungi: a source of potential anticancer compounds. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2017.02536","journal-title":"Front Microbiol"},{"key":"11174_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/md17060339","author":"W Sun","year":"2019","unstructured":"Sun W, Wu W, Liu X, Zaleta-Pinet DA, Clark BR (2019) Bioactive compounds isolated from marine-derived microbes in China: 2009\u20132018. Mar Drugs. https:\/\/doi.org\/10.3390\/md17060339","journal-title":"Mar Drugs"},{"key":"11174_CR47","unstructured":"Schrodinger Vr. Schrodinger, LLC, The PyMOL molecular graphics system, Version 1.3r1. 2010. 2010."},{"issue":"1","key":"11174_CR48","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/jcc.21600","volume":"32","author":"A-R Allouche","year":"2011","unstructured":"Allouche A-R (2011) Gabedit-a graphical user interface for computational chemistry softwares. J Comput Chem 32(1):174\u2013182. https:\/\/doi.org\/10.1002\/jcc.21600","journal-title":"J Comput Chem"},{"issue":"2","key":"11174_CR49","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.jmb.2003.08.031","volume":"333","author":"JA Bertrand","year":"2003","unstructured":"Bertrand JA, Thieffine S, Vulpetti A, Cristiani C, Valsasina B, Knapp S et al (2003) Structural characterization of the GSK-3\u03b2 active site using selective and non-selective ATP-mimetic Inhibitors. J Mol Biol 333(2):393\u2013407. https:\/\/doi.org\/10.1016\/j.jmb.2003.08.031","journal-title":"J Mol Biol"},{"key":"11174_CR50","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455\u2013461. https:\/\/doi.org\/10.1002\/jcc.21334","journal-title":"J Comput Chem"},{"issue":"16","key":"11174_CR51","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS et al (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30(16):2785\u20132791. https:\/\/doi.org\/10.1002\/jcc.21256","journal-title":"J Comput Chem"},{"issue":"3","key":"11174_CR52","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/jcc.26779","volume":"43","author":"TNH Pham","year":"2021","unstructured":"Pham TNH, Nguyen TH, Tam NM, Vu T, Pham NT, Huy NT et al (2021) Improving ligand-ranking of autodock vina by changing the empirical parameters. J Comput Chem 43(3):160\u2013169. https:\/\/doi.org\/10.1002\/jcc.26779","journal-title":"J Comput Chem"},{"key":"11174_CR53","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1\u20132","author":"MJ Abraham","year":"2015","unstructured":"Abraham MJ, Murtola T, Schulz R, P\u00e1ll S, Smith JC, Hess B et al (2015) GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1\u20132:19\u201325. https:\/\/doi.org\/10.1016\/j.softx.2015.06.001","journal-title":"SoftwareX"},{"issue":"2","key":"11174_CR54","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/prot.24350","volume":"82","author":"AE Aliev","year":"2014","unstructured":"Aliev AE, Kulke M, Khaneja HS, Chudasama V, Sheppard TD, Lanigan RM (2014) Motional timescale predictions by molecular dynamics simulations: case study using proline and hydroxyproline sidechain dynamics. Proteins Struct Funct Bioinf 82(2):195\u2013215. https:\/\/doi.org\/10.1002\/prot.24350","journal-title":"Proteins Struct Funct Bioinf"},{"issue":"2","key":"11174_CR55","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79(2):926\u2013935. https:\/\/doi.org\/10.1063\/1.445869","journal-title":"J Chem Phys"},{"issue":"9","key":"11174_CR56","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcc.20035","volume":"25","author":"J Wang","year":"2004","unstructured":"Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA (2004) Development and testing of a general amber force field. J Comput Chem 25(9):1157\u20131174. https:\/\/doi.org\/10.1002\/jcc.20035","journal-title":"J Comput Chem"},{"key":"11174_CR57","unstructured":"Case DA, Ben-Shalom IY, Brozell SR, Cerutti DS, Cheatham TEC, III, V.W.D, Darden TA, et al. AMBER 18. University of California, San Francisco. 2018."},{"issue":"1","key":"11174_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-0500-5-367","volume":"5","author":"AW Sousa da Silva","year":"2012","unstructured":"Sousa da Silva AW, Vranken WF (2012) ACPYPE\u2014antechamber python parser interfacE. BMC Res Notes 5(1):1\u20138. https:\/\/doi.org\/10.1186\/1756-0500-5-367","journal-title":"BMC Res Notes"},{"key":"11174_CR59","unstructured":"Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, et al. Gaussian\u223c09 Revision E.01. 2009."},{"issue":"31","key":"11174_CR60","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1002\/jcc.24502","volume":"37","author":"ST Ngo","year":"2016","unstructured":"Ngo ST, Hung HM, Nguyen MT (2016) Fast and accurate determination of the relative binding affinities of small compounds to HIV-1 protease using non-equilibrium work. J Comput Chem 37(31):2734\u20132742. https:\/\/doi.org\/10.1002\/jcc.24502","journal-title":"J Comput Chem"},{"key":"11174_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2020.107648","volume":"100","author":"NT Mai","year":"2020","unstructured":"Mai NT, Lan NT, Vu TY, Mai Duong PT, Tung NT, Thu Phung HT (2020) Estimation of the ligand-binding free energy of checkpoint kinase 1 via non-equilibrium MD simulations. J Mol Graph Modell 100:107648. https:\/\/doi.org\/10.1016\/j.jmgm.2020.107648","journal-title":"J Mol Graph Modell"},{"issue":"8","key":"11174_CR62","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1063\/1.1740409","volume":"22","author":"RW Zwanzig","year":"1954","unstructured":"Zwanzig RW (1954) High-temperature equation of state by a perturbation method. I Nonpolar Gases J Chem Phys 22(8):1420\u20131426. https:\/\/doi.org\/10.1063\/1.1740409","journal-title":"I Nonpolar Gases J Chem Phys"},{"key":"11174_CR63","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0021-9991(76)90078-4","volume":"22","author":"CH Bennett","year":"1976","unstructured":"Bennett CH (1976) Efficient estimation of free energy differences from monte carlo data. J Comput Phys 22:245\u2013268","journal-title":"J Comput Phys"},{"issue":"21","key":"11174_CR64","doi-asserted-by":"publisher","first-page":"14875","DOI":"10.1039\/D4RA00692E","volume":"14","author":"ST Ngo","year":"2024","unstructured":"Ngo ST, Thai QM, Nguyen TH, Tuan NN, Pham TNH, Phung HTT et al (2024) Alchemical approach performance in calculating the ligand-binding free energy. RSC Adv 14(21):14875\u201314885. https:\/\/doi.org\/10.1039\/D4RA00692E","journal-title":"RSC Adv"},{"key":"11174_CR65","unstructured":"Schr\u00f6dinger LLC P. Schr\u00f6dinger release 2020\u20134: Maestro. 2020."},{"issue":"W1","key":"11174_CR66","doi-asserted-by":"publisher","first-page":"W530","DOI":"10.1093\/nar\/gkab294","volume":"49","author":"MF Adasme","year":"2021","unstructured":"Adasme MF, Linnemann KL, Bolz SN, Kaiser F, Salentin S, Haupt VJ et al (2021) PLIP 2021: expanding the scope of the protein\u2013ligand interaction profiler to DNA and RNA. Nucleic Acids Res 49(W1):W530\u2013W534. https:\/\/doi.org\/10.1093\/nar\/gkab294","journal-title":"Nucleic Acids Res"},{"key":"11174_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717x-7-162","author":"F Haubner","year":"2012","unstructured":"Haubner F, Ohmann E, Pohl F, Strutz J, Gassner HG (2012) Wound healing after radiation therapy: review of the literature. Radiat Oncol. https:\/\/doi.org\/10.1186\/1748-717x-7-162","journal-title":"Radiat Oncol"},{"key":"11174_CR68","first-page":"418","volume-title":"The PreADME approach: web-based program for rapid prediction of physico-chemical, drug absorption and drug-like properties, EuroQSAR 2002 designing drugs and crop protectants: processes, problems and solutions","author":"SK Lee","year":"2003","unstructured":"Lee SK, Lee IH, Kim HJ, Chang GS, Chung JE, No KT (2003) The PreADME approach: web-based program for rapid prediction of physico-chemical, drug absorption and drug-like properties, EuroQSAR 2002 designing drugs and crop protectants: processes, problems and solutions. Blackwell Publishing, Maldenh, pp 418\u2013420"},{"issue":"19","key":"11174_CR69","doi-asserted-by":"publisher","first-page":"4716","DOI":"10.1021\/jm040063i","volume":"47","author":"FX Tavares","year":"2004","unstructured":"Tavares FX, Boucheron JA, Dickerson SH, Griffin RJ, Preugschat F, Thomson SA et al (2004) N-Phenyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amines as potent and selective inhibitors of glycogen synthase kinase 3 with good cellular efficacy. J Med Chem 47(19):4716\u20134730. https:\/\/doi.org\/10.1021\/jm040063i","journal-title":"J Med Chem"},{"issue":"21","key":"11174_CR70","doi-asserted-by":"publisher","first-page":"9107","DOI":"10.1021\/jm201724m","volume":"55","author":"S Berg","year":"2012","unstructured":"Berg S, Bergh M, Hellberg S, H\u00f6gdin K, Lo-Alfredsson Y, S\u00f6derman P et al (2012) Discovery of novel potent and highly selective glycogen synthase kinase-3\u03b2 (GSK3\u03b2) inhibitors for Alzheimer\u2019s disease: design, synthesis, and characterization of pyrazines. J Med Chem 55(21):9107\u20139119. https:\/\/doi.org\/10.1021\/jm201724m","journal-title":"J Med Chem"},{"issue":"5","key":"11174_CR71","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1016\/j.bmcl.2010.01.072","volume":"20","author":"M Arnost","year":"2010","unstructured":"Arnost M, Pierce A, Et H, Lauffer D, Madden J, Tanner K et al (2010) 3-Aryl-4-(arylhydrazono)-1H-pyrazol-5-ones: highly ligand efficient and potent inhibitors of GSK3\u03b2. Bioorg Med Chem Lett 20(5):1661\u20131664. https:\/\/doi.org\/10.1016\/j.bmcl.2010.01.072","journal-title":"Bioorg Med Chem Lett"},{"issue":"12","key":"11174_CR72","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1021\/acsmedchemlett.0c00500","volume":"11","author":"RW Sabnis","year":"2020","unstructured":"Sabnis RW (2020) Novel CDK2 inhibitors for treating cancer. ACS Med Chem Lett 11(12):2346\u20132347. https:\/\/doi.org\/10.1021\/acsmedchemlett.0c00500","journal-title":"ACS Med Chem Lett"},{"issue":"15","key":"11174_CR73","doi-asserted-by":"publisher","first-page":"7224","DOI":"10.1080\/07391102.2022.2118830","volume":"41","author":"T-T-H Le","year":"2023","unstructured":"Le T-T-H, Tran LH, Nguyen MT, Pham MQ, Phung HTT (2023) Calculation of binding affinity of JAK1 inhibitors via accurately computational estimation. J Biomol Struct Dyn 41(15):7224\u20137234. https:\/\/doi.org\/10.1080\/07391102.2022.2118830","journal-title":"J Biomol Struct Dyn"},{"key":"11174_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2022.108230","volume":"115","author":"QM Thai","year":"2022","unstructured":"Thai QM, Pham TNH, Hiep DM, Pham MQ, Tran P-T, Nguyen TH et al (2022) Searching for AChE inhibitors from natural compounds by using machine learning and atomistic simulations. J Mol Graph Modell 115:108230. https:\/\/doi.org\/10.1016\/j.jmgm.2022.108230","journal-title":"J Mol Graph Modell"},{"issue":"19","key":"11174_CR75","doi-asserted-by":"publisher","first-page":"6825","DOI":"10.1073\/pnas.0409005102","volume":"102","author":"H-J Woo","year":"2005","unstructured":"Woo H-J, Roux B (2005) Calculation of absolute protein-ligand binding free energy from computer simulations. Proc Natl Acad Sci U S A 102(19):6825\u20136830. https:\/\/doi.org\/10.1073\/pnas.0409005102","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"11174_CR76","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1021\/acs.jcim.7b00037","volume":"57","author":"\u00c9CM Nascimento","year":"2017","unstructured":"Nascimento \u00c9CM, Oliva M, \u015awiderek K, Martins JBL, Andr\u00e9s J (2017) Binding analysis of some classical acetylcholinesterase inhibitors: insights for a rational design using free energy perturbation method calculations with QM\/MM MD simulations. J Chem Inf Model 57(4):958\u2013976. https:\/\/doi.org\/10.1021\/acs.jcim.7b00037","journal-title":"J Chem Inf Model"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11174-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-025-11174-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11174-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T15:56:48Z","timestamp":1771775808000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-025-11174-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,2]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["11174"],"URL":"https:\/\/doi.org\/10.1007\/s11030-025-11174-x","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,2]]},"assertion":[{"value":"17 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ehical approval"}}]}}